Company / EPS (Diluted)
KIORA PHARMACEUTICALS INC EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.87
FY2025
5-year range
-$24.25 / $0.87
FY2021-FY2025
Trend
+103.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 7 years, ranging from $-24.25 in FY2024 to $0.87 in FY2025.
Based on SEC 10-K filings.
0.87 in FY2025.
Improved from $-1.77 to $0.87 over the past 4 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 103.6% year-over-year.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.87 | +103.6% |
| FY2024 | -$24.25 | -1270.1% |
| FY2021 | -$1.77 | +20.6% |
| FY2020 | -$2.23 | +51.2% |
| FY2019 | -$4.57 | -391.4% |
| FY2018 | -$0.93 | - |
| FY2017 | - | - |
| FY2016 | -$2.70 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026